Single Nucleotide Polymorphism (SNP) Genotyping Market, By Product Type (Microarrays, GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequenom MassArray Maldi-TOF, Other), By Application (Diagnostic Research, Pharmacogenomics, Agricultural Biotechnology, Breeding and Animal Livestock), By Country, and By Region Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
REPORT HIGHLIGHT
Single Nucleotide Polymorphism (SNP) Genotyping Market size was valued at USD 12,807.2 million in 2022, expanding at a CAGR of 20.5% from 2023 to 2030.
Single nucleotide polymorphisms are the most common type of genetic variation among people. Each SNP represents a difference in a single DNA building block, called a nucleotide. SNPs occur normally throughout a person’s DNA. They occur almost once in every 1,000 nucleotides on average, which means there are roughly 4 to 5 million SNPs in a person's genome. These variations occur in many individuals; to be classified as an SNP, a variant is found in at least 1 percent of the population. Experts have found more than 600 million SNPs in populations around the world. Detecting a change in a single nucleotide can provide essential insights if it is associated with a particular disease or a relevant phenotype. For example, certain SNPs are associated with heart disease, immune dysfunction, cancer, and many other diseases.
Single Nucleotide Polymorphism (SNP) Genotyping Market- Market Dynamics
- The growing demand for genetic analysis in animal and plant feedstock increasing the market growth.
The growing demand for genetic analysis in animal and plant feedstock has indeed led to an increased demand for Single Nucleotide Polymorphism (SNP) genotyping, consequently driving the market's growth. Rapeseed is the most important oil crop used in the food and biodiesel industries. Based on single nucleotide polymorphism (SNP) identified from genotyping-by-sequencing (GBS), and an association study of flowering time, crude fat and fatty acid contents were investigated in 46 rapeseed mutant lines derived from gamma rays. According to the FAO, the global population will approach 10 billion people by the year 2050 while the economic status of people in developing countries will continue to improve. As a result, there will be a profound increase in demand for animal products. Increasing animal production will require gaining a deeper understanding of animal biology through genomics and associated sciences to enable U.S. livestock, poultry, and aquaculture producers to maintain global competitiveness and adapt to changing climates and the need to reduce greenhouse gas emissions.
Single Nucleotide Polymorphism (SNP) Genotyping Market- Key Insights
- As per the analysis shared by our research analyst, the global Nucleotide Polymorphism (SNP) Genotyping market is estimated to grow annually at a CAGR of around 20.5% over the forecast period (2023-2030)
- The Nucleotide Polymorphism (SNP) Genotyping industry is projected to grow at a significant rate due to the growing awareness of sustainable growth
- Based on Product type segmentation, SNP Pyrosequencing was predicted to show maximum market share in the year 2022
- Based on Application segmentation, Pharmacogenomics was the leading type in 2022
- On the basis of region, North America was the leading revenue generator in 2022
Single Nucleotide Polymorphism (SNP) Genotyping Market- Segmentation Analysis:
The Global Single Nucleotide Polymorphism (SNP) Genotyping Market is segmented on the basis of Product Type, Application, and Region.
The market is divided into three categories based on product type: Microarrays, GeneChips, Taqman Allelic Discrimination, SNP Pyrosequencing, Applied Biosciences SNPlex, Sequenom MassArray Maldi-TOF and Other. SNP Pyrosequencing dominates the market. Pyrosequencing is a sequencing technique that allows for the real-time detection of DNA synthesis. It is particularly useful for analyzing short DNA sequences and can be adapted for SNP genotyping.
The market is divided into two categories based on application: Diagnostic Research, Pharmacogenomics, Agricultural Biotechnology, Breeding, and Animal Livestock. Pharmacogenomics dominates the market and is likely to maintain its dominance during the forecast period. Nucleotide Polymorphism (SNP) genotyping is a key technique used in pharmacogenomics to identify genetic variations that can impact drug response.
Single Nucleotide Polymorphism (SNP) Genotyping Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the Single Nucleotide Polymorphism (SNP) Genotyping market, due to the rising prevalence of fatal diseases such as cancer, diabetes, Alzheimer's disease, and others. SNPs are beneficial markers of complex gene disease. Many common and serious diseases, such as Alzheimer's disease, have associated SNPs. Detection of SNP biomarkers linked with AD could help in the early prediction and diagnosis of this disease. The number of Americans living with Alzheimer's is growing and growing fast. More than 6 million Americans of all ages have Alzheimer's. An estimated 6.7 million Americans age 65 and older are living with Alzheimer's in 2023. Seventy-three percent are age 75 or older, according to Alzheimer's Association. Europe and Asia Pacific markets are emerging owing to the development of various, rising incidences of targeted diseases, improvements in healthcare services, and increasing demand for personalized medicines.
Single Nucleotide Polymorphism (SNP) Genotyping Market- Competitive Landscape:
Several academic and research institutions contribute to the competitive landscape by developing novel SNP genotyping technologies and methods. These organizations often collaborate with industry players or offer their technologies through licensing agreements. Products makers compete on a variety of aspects, including product costs, performance, product making, technology, reputation, and availability. Some of the primary techniques used by corporations to support their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, In May 2023, Illumina Inc., a global leader in DNA sequencing and array-based technologies, nowadays recognized the progress and impact of genomic technologies on pathogen preparedness and response.
Recent Developments:
- In April 2023, a New single-nucleotide polymorphism chip can help identify genetic markers of desirable traits in rice. The researchers developed the custom SNP array by collecting and sequencing genetic samples belonging to 3,024 rice samples from around the world. From more than 18.9 million high-quality SNPs from this sample, approximately 2.5 million polymorphic SNPs were identified and retained in the array design.
Key features of the study:
- This proposed research study on Single Nucleotide Polymorphism (SNP) Genotyping market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
- The report provides the client the latest up-to-date and trending insights about the Single Nucleotide Polymorphism (SNP) Genotyping market.
- The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Single Nucleotide Polymorphism (SNP) Genotyping market
- The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Single Nucleotide Polymorphism (SNP) Genotyping market
- Impact of COVID-19 on Single Nucleotide Polymorphism (SNP) Genotyping market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Single Nucleotide Polymorphism (SNP) Genotyping market post-COVID will also be covered.
- In order to give the users of this report a comprehensive view on the Single Nucleotide Polymorphism (SNP) Genotyping market, we have also included competitive landscape and key innovator analysis for the Single Nucleotide Polymorphism (SNP) Genotyping market.
- The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
- The report offers detailed company profiling featuring major market participants which will help users to understand their financial information and strategic initiatives of players operating in the Single Nucleotide Polymorphism (SNP) Genotyping market.
- In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
- The global Single Nucleotide Polymorphism (SNP) Genotyping market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET KEY PLAYERS
- Sequenom, Inc.
- Douglas Scientific LLC
- PREMIER Biosoft
- Sequenom Inc.
- Luminex Corp.
- Life Technologies Corp.
- Fluidigm
- Illumina, Inc.
- Affymetrix, Inc.
GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY PRODUCT TYPE
- Microarrays
- GeneChips
- Taqman Allelic Discrimination
- SNP Pyrosequencing
- Applied Biosciences SNPlex
- Sequenom MassArray Maldi-TOF
- Other
GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY APPLICATION
- Diagnostic Research
- Pharmacogenomics
- Agricultural Biotechnology
- Breeding and Animal Livestock
GLOBAL SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Single Nucleotide Polymorphism (SNP) Genotyping Market Overview
1.1. Study Scope
2. Executive Summary
2.1. Market Snippet
2.1.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Snippet by Product Type
2.1.2. Single Nucleotide Polymorphism (SNP) Genotyping Market Snippet by Application
2.1.3. Single Nucleotide Polymorphism (SNP) Genotyping Market Snippet by Country
2.1.4. Single Nucleotide Polymorphism (SNP) Genotyping Market Snippet by Region
2.2. Competitive Insights
3. Single Nucleotide Polymorphism (SNP) Genotyping Key Market Trends
3.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Single Nucleotide Polymorphism (SNP) Genotyping Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Single Nucleotide Polymorphism (SNP) Genotyping Market Opportunities
3.4. Single Nucleotide Polymorphism (SNP) Genotyping Market Future Trends
4. Single Nucleotide Polymorphism (SNP) Genotyping Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Single Nucleotide Polymorphism (SNP) Genotyping Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Single Nucleotide Polymorphism (SNP) Genotyping Market Landscape
6.1. Single Nucleotide Polymorphism (SNP) Genotyping Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Single Nucleotide Polymorphism (SNP) Genotyping Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
7.1.2. Microarrays
7.1.3. GeneChips
7.1.4. Taqman Allelic Discrimination
7.1.5. SNP Pyrosequencing
7.1.6. Applied Biosciences SNPlex
7.1.7. Sequenom MassArray Maldi-TOF
7.1.8. Other
8. Single Nucleotide Polymorphism (SNP) Genotyping Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
8.1.2. Diagnostic Research
8.1.3. Pharmacogenomics
8.1.4. Agricultural Biotechnology
8.1.5. Breeding and Animal Livestock.
9. Single Nucleotide Polymorphism (SNP) Genotyping Market– By Geography
9.1. Introduction
9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
9.2. North America
9.2.1. Overview
9.2.2. Single Nucleotide Polymorphism (SNP) Genotyping Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.6. U.S.
9.2.6.1. Overview
9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.6.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.2.6.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.2.7. Canada
9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.2.7.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.2.7.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3. Europe
9.3.1. Overview
9.3.2. Single Nucleotide Polymorphism (SNP) Genotyping Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.6. Germany
9.3.6.1. Overview
9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.6.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.6.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.7. Italy
9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.7.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.7.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.8. United Kingdom
9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.8.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.8.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.9. France
9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.9.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.9.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.10. Russia
9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.10.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.10.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.11. Netherlands
9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.11.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.11.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.12. Sweden
9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.12.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.12.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.13. Poland
9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.13.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.13.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.3.14. Rest of Europe
9.3.14.1. Overview
9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.3.14.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.3.14.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4. Asia Pacific (APAC)
9.4.1. Overview
9.4.2. Single Nucleotide Polymorphism (SNP) Genotyping Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.6. India
9.4.6.1. Overview
9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.6.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.6.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.7. China
9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.7.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.7.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.8. Japan
9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.8.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.8.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.9. South Korea
9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.9.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.9.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.10. Australia
9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.10.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.10.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.11. Thailand
9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.11.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.11.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.12. Indonesia
9.4.12.1. Overview
9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.12.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.13. Philippines
9.4.13.1. Overview
9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.13.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.13.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.4.14. Rest of APAC
9.4.14.1. Overview
9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.4.14.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.4.14.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5. Latin America
9.5.1. Overview
9.5.2. Single Nucleotide Polymorphism (SNP) Genotyping Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.6. Brazil
9.5.6.1. Overview
9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.6.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.6.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.7. Mexico
9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.7.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.7.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.8. Argentina
9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.8.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.8.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.9. Colombia
9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.9.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.9.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.5.10. Rest of LATAM
9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.5.10.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.5.10.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6. Middle East and Africa
9.6.1. Overview
9.6.2. Single Nucleotide Polymorphism (SNP) Genotyping Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.6. Saudi Arabia
9.6.6.1. Overview
9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.6.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.6.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.7. United Arab Emirates
9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.7.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.7.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.8. Israel
9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.8.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.8.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.9. Turkey
9.6.9.1. Overview
9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.9.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.9.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.10. Algeria
9.6.10.1. Overview
9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.10.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.10.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.11. Egypt
9.6.11.1. Overview
9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.11.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.11.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
9.6.12. Rest of MEA
9.6.12.1. Overview
9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
9.6.12.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
9.6.12.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
10. Key Vendor Analysis- Single Nucleotide Polymorphism (SNP) Genotyping Industry
10.1. Competitive Dashboard
10.2. Company Profiles
10.2.1. Sequenom, Inc.
10.2.2. Douglas Scientific LLC
10.2.3. PREMIER Biosoft
10.2.4. Sequenom Inc.
10.2.5. Luminex Corp.
10.2.6. Life Technologies Corp.
10.2.7. Fluidigm
10.2.8. Illumina, Inc.
10.2.9. Affymetrix, Inc.
11. 360 Degree Analyst View
12. Appendix
12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us
